Nutrition Education in Cardiac Rehabilitation

Status Completed

Clinical Trial Summary

Coronary heart disease is one of the United Kingdom's biggest killers. In the UK alone 175,000 myocardial infarctions are recorded annually. To lower the financial burden on the National Health Service, cardiac rehabilitation facilitates a systematic and multidisciplinary approach to secondary prevention aimed to improve functional capacity and health-related quality of life, lower rehospitalisation rates and reduce all-cause and cardiovascular mortality with exercise training being the cornerstones. The effectiveness of Cardiac rehabilitation programmes in delivering effective secondary prevention has long been established. Improvements are recorded in cardiovascular endurance, muscular strength and endurance, balance, co-ordination, and quality of life. However, many patients see little or no change in body mass and body mass index, an independent risk factor for coronary heart disease. Interestingly, the inclusion of nutrition education is rarely reported within specific Cardiac rehabilitation settings, therefore evidence of best practice remains elusive and warrants further investigation. The aim of this trial is to compare: - Usual care - Where patients access to two exercise classes per week and all facilities normally available as part of their cardiac rehabilitation programme. Patients in this group will undergo this approach for 12-weeks. - Usual care + Biggest loser - In addition to Usual care, patients in this group took part in the 'Biggest loser' program in which the patients attended weekly sessions outside of their usual exercise class times. Each session follows a specific theme based on British Heart Foundation healthy eating guidelines. Participants will undergo this approach for 6-weeks and then switch to usual care for 6-weeks. - Usual care + New Education programme. In addition to Usual care, the same weekly topics as the biggest loser are covered yet with bespoke information regarding portion sizes and recipes provided each week and patients given a challenge each week in relation to the topic being covered e.g. include more vegetables. Participants will undergo this approach for 6-weeks and then switch to usual care for 6-weeks. Patients will be tested at baseline, 6-weeks and 12-weeks.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05198024
Study type	Interventional
Source	University of Central Lancashire
Contact
Status	Completed
Phase	N/A
Start date	January 1, 2018
Completion date	January 1, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05880758` - Impact of Yo-Yo Sleep on Cardiometabolic Health	N/A
Active, not recruiting	`NCT05192590` - Establishing Clinical Utility Evidence for Chronic Disease Management Testing	N/A
Completed	`NCT06058845` - Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV	N/A
Completed	`NCT05473026` - Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors	N/A
Enrolling by invitation	`NCT06284772` - FINRISK 2002 Re-examination
Completed	`NCT05071833` - Effects of Peppermint Oil in Cardiometabolic Outcomes	N/A
Active, not recruiting	`NCT05309057` - Network Meta-analysis of Intermittent Fasting and Cardiometabolic Risk
Recruiting	`NCT05897073` - Time-Restricted Eating, Exercise and Cardiometabolic Health in Obesity	N/A
Recruiting	`NCT06371937` - iPSC Biobank of Biomarkers Diversity in Cardiovascular Disease
Recruiting	`NCT06003686` - Spinal Cord Injury Model Systems (SCIMS) - Education Module	N/A
Recruiting	`NCT05775016` - Effects of Adding L-BAIBA to Exercising Adult Overweight and Obese Men and Women	N/A
Recruiting	`NCT05350111` - CArdioMetabolic Prevention in Adolescents	N/A
Completed	`NCT06158191` - Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study)	N/A
Recruiting	`NCT04801745` - Vegan Diet, Amla Fruits and Uric Acid	N/A
Not yet recruiting	`NCT06230861` - Effects of Quercetin on Cardiometabolic Outcomes	N/A
Active, not recruiting	`NCT05627570` - A Study Comparing the Health Effects of Two Diets Following UK Dietary Guidance in People Living With Overweight or Obesity	N/A
Active, not recruiting	`NCT04784624` - Virtual Lifestyle Program Evaluation During Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Enrolling by invitation	`NCT05079529` - Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome	Phase 2
Completed	`NCT04776629` - A Proof-of-Activity Study With Orticumab in Subjects With Psoriasis and Cardiometabolic Risk Factors	Phase 2
Completed	`NCT06457711` - Blood Pressure and Cardiometabolic Risk (Diet-to-HTN)	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.